CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The high prevalence rate of lifestyle diseases, infectious diseases, and genetic
disorders
4.1.2. Increasing demand for protein-based drugs
4.1.3. Growing funding for protein research
4.1.4. Intense research and development of novel pharmaceuticals in various categories
4.1.5. Technological advancements in molecular biology and bioinformatics
4.2. Market Restraints & Challenges
4.2.1. The high cost of protein therapy
4.2.2. High market consolidation with entry barriers
4.3. Market Opportunities
4.3.1. Developing countries
4.3.2. Untapped growth potential of the market
CHAPTER 5 GLOBAL EXPRESSION VECTORS MARKET – BY HOST TYPE
5.1. Bacterial
5.2. Yeast
5.3. Insect
5.4. Mammalian
CHAPTER 6 GLOBAL EXPRESSION VECTORS MARKET – BY APPLICATION
6.1. Therapeutic Applications
6.2. Industrial Applications
6.3. Research Applications
CHAPTER 7 GLOBAL EXPRESSION VECTORS MARKET – BY END USER
7.1. Pharmaceutical and Biotechnology Companies
7.2. CROS and CMOS
7.3. Academic Research Institutes
7.4. Others
CHAPTER 8 GLOBAL EXPRESSION VECTORS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL EXPRESSION VECTORS MARKET - COMPANY PROFILES
9.1. Thermo Fisher Scientific, Inc.
9.2. Sigma Aldrich Corporation
9.3. Agilent Technologies
9.4. Bio-Rad Laboratories
9.5. Promega Corporation
9.6. New England Biolabs
9.7. Life Tech Corporation
9.8. Clontech Laboratories, Inc.
9.9. Merck Millipore
9.10. Genscript, Inc.
9.11. Qiagen
9.12. ATUM bioengineering solutions
9.13. Life Science Research
CHAPTER 10 GLOBAL EXPRESSION VECTORS MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
